Thoughtful delivery service

Easy 30 day returns

Certified Reviews

Description

GP100060: IFNα2b(102-108)-Tn(105)C44H71N9O19 903. 97 Synthetic glycopeptide fragment of Interferon alpha 2b, IFN2b, marketed for therapeutic use as Intron A. The peptide sequence VGVTETP corresponds to positions 103 109 of the mature IFN2b protein with GalNAc glycosylation (Tn Antigen) ocurring at Thr105. The C terminus is an amide. IFN2b(102 108) Tn(105) Interferon alpha IFN2b(Tn) glycopeptide

C38H50N2O11 / 710

MGL/CLEC10A) research

36 / IgA1 synthetic Hinge Region peptide fragment from Val222 to Cys241 with glycosylation (α-GalNAc) at Thr228

α2-3 sialosides are ligands for selectins and certain Siglecs

C56H65N3O24 / 1164

Two sequential enzymatic reactions are typically required: removal of the 2-O-sulfate by IDS

/ α-D-GalNAc-Ser-NH-Biotin / Biotinyl Tn Antigen (Serine)

/ MUC5AC(2449-2464)-Tn(2451

and investigations into the mechanism of action

C-terminal methyl ester L-threonine glycoamino acid carrying a Galβ1-3GalNAcα disaccharide (T antigen)

This is the standard fluorogenic substrate for iduronate-2-sulfatase (IDS)

Fmoc-L-Ser(Neu5Acα(2-6)GalNAc)-OH (Peracetate